Skip to Content
Merck
  • Diuretic Action of Apelin-13 Mediated by Inhibiting cAMP/PKA/sPRR Pathway.

Diuretic Action of Apelin-13 Mediated by Inhibiting cAMP/PKA/sPRR Pathway.

Frontiers in physiology (2021-04-20)
Yanting Chen, Chuanming Xu, Jiajia Hu, Mokan Deng, Qixiang Qiu, Shiqi Mo, Yanhua Du, Tianxin Yang
ABSTRACT

Emerging evidence is showing that apelin plays an important role in regulating salt and water balance by counteracting the antidiuretic action of vasopressin (AVP). However, the underlying mechanism remains unknown. Here, we hypothesized that (pro) renin receptor (PRR)/soluble prorenin receptor (sPRR) might mediate the diuretic action of apelin in the distal nephron. During water deprivation (WD), the urine concentrating capability was impaired by an apelin peptide, apelin-13, accompanied by the suppression of the protein expression of aquaporin 2 (AQP2), NKCC2, PRR/sPRR, renin and nuclear β-catenin levels in the kidney. The upregulated expression of AQP2 or PRR/sPRR both induced by AVP and 8-Br-cAMP was blocked by apelin-13, PKA inhibitor (H89), or β-catenin inhibitor (ICG001). Interestingly, the blockage of apelin-13 on AVP-induced AQP2 protein expression was reversed by exogenous sPRR. Together, the present study has defined the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)/sPRR pathway in the CD as the molecular target of the diuretic action of apelin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Water Channel Aquaporin 2 antibody produced in rabbit, IgG fraction of antiserum, lyophilized powder
Sigma-Aldrich
Anti-SLC12A1 antibody produced in rabbit, 1 mg/mL, affinity isolated antibody